We also assessed residual cancer burden (RCB) scores on surgical specimens of non-pCR patients by using the Web-based MD Anderson RCB calculator and its relationship with CD8+ TIL, FOXP3+ TIL, and CD8/FOXP3 ratio [33]. This evidence concerns the gene FOXP3 and cancer.